Xiamen Tongrenxin Biotechnology Co., Ltd. focuses on the R&D, production and sales of bioactive raw materials for in vitro diagnostic reagents.
Relying on the in-depth cooperation in production, education and research of "National Key Laboratory of Molecular Vaccinology and Molecular Diagnostics" and "National Research Center for Infectious Disease Diagnostic Reagents and Vaccine Engineering Technology", the company is committed to establishing a core raw material platform for high-quality, original research and development of diagnostic reagents. At present, the company's raw material products cover molecular diagnosis, luminescence/enzyme-linked immunosorbent assay, colloidal gold/fluorescence chromatography and other platforms, and has launched more than 100 mature and stable products such as nucleic acid detection tool enzymes, immune major infectious disease detection, infection indicators, myocardial markers, tumor markers, etc. The company has established a mature antigen and antibody raw material development system, and can launch 4-6 innovative new products every year.
Adhering to a serious scientific attitude and the product concept of keeping improving, Tongrenxin Bio is willing to provide high-quality core raw materials and technologies for in vitro diagnostic reagent manufacturers worldwide.